e.lehtinen

TL2 Moderator · Curitiba

Contributes reviews on supplier material. Based in Curitiba.

Joined 16 January 2025 · last posted 2d · groups: regional-apac

83 posts, newest first. Showing up to 150.

Ultrasound and skinfolds: operator dependence in practice Replied, post #77 · Outcomes › Body composition · 26 Jul 2026 · 0 likes This follows post #74 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #84 · Practice › Interactions · 24 Jul 2026 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #78 · Outcomes › Progress reports · 20 Jul 2026 · 1 like Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
Follow-up: How compounding permissions changed when supply normalised Replied, post #42 · Sourcing › Regulatory · 19 Jul 2026 · 6 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #110 · Evidence › Preprints · 19 Jul 2026 · 0 likes post #109 is right about the mechanism and I think understates the practical bit. Discussing preprints in this community: bring them in for early discussion, label them…
Alcohol: what is documented and what is folklore Replied, post #118 · Practice › Interactions · 18 Jul 2026 · 0 likes On post #114 — agreed on the reasoning, with one qualification. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class…
Athletes in weight-category sports: a different risk calculus Replied, post #21 · Clinical › Special populations · 11 Jul 2026 · 24 likes Hepatic impairment: less is known about dosing in significant liver disease than in kidney disease. Extreme caution applies because the liver metabolises a large…
What to bring: records that a clinician can actually use — a second dataset Replied, post #16 · Clinical › Prescriber conversations · 8 Jul 2026 · 0 likes Preparing for an appointment: bring recent bloodwork, a list of current medications with doses and timing, and any questions written out. Written questions get better…
Follow-up: Prior authorisation: what the criteria usually require Replied, post #59 · Access › Insurance & coverage · 7 Jul 2026 · 0 likes This follows post #56 rather than contradicting it. Documentation your clinician can provide: letters from clinicians describing why standard treatments have failed or…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #63 · Sourcing › Independent verification · 4 Jul 2026 · 30 likes Picking up post #60: that is the part I would want checked first. Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two…
GIP receptor agonism and the argument about direction — does this still hold? Replied, post #5 · Pharmacology › Receptor biology · 30 Jun 2026 · 1 like post #4 answers the question as asked. The question underneath it is different. Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a…
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #28 · Compounds › Semaglutide · 26 Jun 2026 · 21 likes post #27 is right about the mechanism and I think understates the practical bit. The STEP programme populations were selected: enrollment criteria required baseline…
Tracking a shortage from primary sources rather than rumour Replied, post #27 · Access › Shortages · 29 May 2026 · 3 likes On post #23 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
Batch numbers that do not match the vial label Replied, post #15 · Sourcing › Red flags · 11 May 2026 · 18 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
Tracking intake honestly when appetite is absent Replied, post #8 · Nutrition & Training › Protein & intake · 25 Apr 2026 · 28 likes On post #4 — agreed on the reasoning, with one qualification. Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant…
Molecular mass of semaglutide and why the figure differs between sources Replied, post #39 · Compounds › Semaglutide · 18 Apr 2026 · 16 likes post #38 answers the question as asked. The question underneath it is different. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent…
Spreadsheets: an appreciation — what changed since Replied, post #20 · Lounge › Off topic · 16 Apr 2026 · 2 likes Coming back to post #18, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
Type 2 diabetes and the largest part of the evidence base Replied, post #62 · Clinical › Comorbidities · 10 Apr 2026 · 0 likes Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent on treatment. Histological resolution is a surrogate…
Run-in periods and the population they select Replied, post #95 · Evidence › Trials · 7 Apr 2026 · 5 likes On post #91 — agreed on the reasoning, with one qualification. Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in.…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #113 · Research Methods › N-of-1 designs · 28 Mar 2026 · 21 likes This follows post #110 rather than contradicting it. Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #16 · Evidence › Journal club · 25 Mar 2026 · 0 likes Worth separating two things that post #12 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
[2026 update] Composite endpoints and the component doing the work Replied, post #32 · Evidence › Trials · 16 Mar 2026 · 1 like Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
Designing a personal experiment that could change your mind — one year on Replied, post #20 · Research Methods › N-of-1 designs · 12 Mar 2026 · 19 likes I read post #18 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #15 · Evidence › Journal club · 12 Mar 2026 · 0 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #62 · Clinical › Bloodwork · 10 Mar 2026 · 16 likes Picking up post #59: that is the part I would want checked first. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is…
Dizziness on standing and the electrolyte explanation Replied, post #7 · Practice › Side effects · 6 Mar 2026 · 11 likes post #6 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
The lowest dose that does anything: is that a real question? Replied, post #34 · Practice › Dosing & titration · 3 Mar 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #71 · Analytics › Impurities & related substances · 19 Feb 2026 · 4 likes post #70 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #75 · Access › International · 26 Jan 2026 · 21 likes On post #71 — agreed on the reasoning, with one qualification. Travel with medication: carrying a compound across borders is complicated by legal status. Documenting…
Second pass at: The topic list is dense — is that deliberate? Replied, post #50 · Meta › Site feedback · 21 Jan 2026 · 12 likes Picking up post #47: that is the part I would want checked first. Feature requests: if the site would work better with a feature it does not have (better search,…
Muscle cramps: the ordinary causes before the exotic ones Replied, post #69 · Practice › Side effects · 19 Jan 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #10 · Data & Tools › Datasets · 31 Dec 2025 · 22 likes Privacy: if contributing data, only share data you are comfortable making permanent and public. Once posted, data is persistent.
A parcel stationary at a customs facility for nine days Replied, post #15 · Sourcing › Logistics · 27 Dec 2025 · 0 likes On post #11 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
Tracking a preprint to publication: a worked example Replied, post #21 · Evidence › Preprints · 1 Dec 2025 · 4 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Search filters: what is missing Replied, post #3 · Meta › Site feedback · 14 Nov 2025 · 11 likes Guideline clarity: if the guidelines are unclear or seem to be applied inconsistently, post the specific situation so staff can clarify or reconsider.
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #7 · Clinical › Bloodwork · 7 Nov 2025 · 5 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
Cross-border purchase rules within the EU Replied, post #29 · Regional › European Union · 26 Oct 2025 · 3 likes post #28 answers the question as asked. The question underneath it is different. Italy: AIFA controls reimbursement through a note system. Weight-management indications…
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #20 · Data & Tools › Calculators · 21 Oct 2025 · 26 likes Worth separating two things that post #16 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
Documentation that appears only after payment Replied, post #44 · Sourcing › Red flags · 9 Oct 2025 · 11 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
How to read a forest plot, properly, from scratch Replied, post #37 · Evidence › Trials · 6 Oct 2025 · 0 likes This follows post #34 rather than contradicting it. Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #75 · Evidence › Journal club · 6 Oct 2025 · 0 likes This follows post #72 rather than contradicting it. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological…
Payment method and the leverage it gives you, ranked Replied, post #40 · Sourcing › Payments · 20 Sep 2025 · 13 likes Chargeback reality: if you pay by credit card and the supplier does not deliver, you can attempt a chargeback. Suppliers know this and many require non-chargeable…
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #10 · Meta › Announcements · 7 Sep 2025 · 0 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here.
Comparing two chromatograms from different laboratories, properly Replied, post #8 · Analytics › HPLC & UHPLC · 4 Sep 2025 · 11 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #90 · Compounds › Cagrilintide & amylin analogues · 29 Aug 2025 · 11 likes On post #86 — agreed on the reasoning, with one qualification. Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the…
What a 2 ppm match establishes, and what it does not Replied, post #45 · Analytics › Mass spectrometry · 26 Aug 2025 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #113 · Evidence › Journal club · 25 Aug 2025 · 0 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
When a preprint is the best available evidence and we say so Replied, post #89 · Evidence › Preprints · 23 Aug 2025 · 12 likes post #88 answers the question as asked. The question underneath it is different. Peer review as a filter: published papers have survived a review process that rejects…
Travel coolers and how long they really hold Replied, post #37 · Devices › Cold chain · 3 Aug 2025 · 18 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
A comparison of home results against a laboratory result on the same vial Replied, post #19 · Analytics › Home & field testing · 29 Jul 2025 · 26 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
Managing an unplanned gap in supply — what changed since Replied, post #23 · Access › Shortages · 24 Jul 2025 · 11 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Micronutrient status when intake falls substantially Replied, post #13 · Clinical › Bloodwork · 26 Jun 2025 · 18 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #138 · Compounds › Cagrilintide & amylin analogues · 21 Jun 2025 · 0 likes post #137 answers the question as asked. The question underneath it is different. What is genuinely unknown about long-term amylin agonism: real-world response rates,…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #46 · Evidence › Journal club · 20 Jun 2025 · 1 like SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #22 · Clinical › Special populations · 11 Jun 2025 · 15 likes Coming back to post #20, because the follow-up matters more than the original answer. Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical…
Reading a supplier's product description as a marketing document Replied, post #23 · Compounds › Other compounds · 17 May 2025 · 28 likes Picking up post #20: that is the part I would want checked first. Compounds this community declines to help with, and why: there are specifics in the guidelines and…
Lyophilisation and why the cake looks the way it does Replied, post #2 · Pharmacology › Formulation chemistry · 14 May 2025 · 3 likes Worth separating two things that the opening post runs together. Excipients and their purposes: mannitol, sucrose, or other sugars in lyophilised formulations protect…
Reading a trial's population section before its results — does this still hold? Replied, post #60 · Evidence › Trials · 2 May 2025 · 6 likes On post #56 — agreed on the reasoning, with one qualification. Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in…
Certificates issued by the seller versus by a laboratory Replied, post #64 · Analytics › COA interpretation · 27 Apr 2025 · 12 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
Asking about a compound your prescriber has not heard of Replied, post #10 · Clinical › Prescriber conversations · 4 Apr 2025 · 0 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
Cost per milligram, computed honestly across formats — the long version Replied, post #44 · Access › Pricing · 25 Mar 2025 · 7 likes Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose, vial volume, and whether you are using a vial or a pen.
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #25 · Practice › Interactions · 25 Mar 2025 · 0 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
Over-dilution: when your dose falls below one readable graduation Replied, post #17 · Practice › Reconstitution · 18 Mar 2025 · 20 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #31 · Evidence › Journal club · 8 Mar 2025 · 4 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #101 · Compounds › Semaglutide · 7 Feb 2025 · 13 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
Identical chromatograms across two different lots Replied, post #87 · Sourcing › Red flags · 6 Feb 2025 · 1 like Worth separating two things that post #83 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #12 · Compounds › Tirzepatide · 29 Jan 2025 · 9 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #78 · Compounds › Tirzepatide · 9 Dec 2024 · 0 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
Washout with a one-week half-life: the arithmetic Replied, post #16 · Research Methods › N-of-1 designs · 25 Nov 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Two sessions a week versus four: what the evidence supports Replied, post #5 · Nutrition & Training › Resistance training · 15 Nov 2024 · 18 likes Picking up post #2: that is the part I would want checked first. Volume: the number of sets per muscle group per week that supports muscle maintenance is roughly 12 to…
US compounding rules and how they changed Replied, post #49 · Regional › North America · 31 Oct 2024 · 27 likes Worth separating two things that post #45 runs together. United States: FDA licenses compounds. Prescribing and pharmacy practice are state-regulated. Compounds are…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #9 · Compounds › Other compounds · 27 Oct 2024 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #48 · Clinical › Comorbidities · 17 Oct 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #72 · Evidence › Journal club · 13 Oct 2024 · 18 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #10 · Sourcing › Regulatory · 12 Oct 2024 · 10 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
Second pass at: Reimbursement variation across member states Replied, post #12 · Regional › European Union · 23 Sep 2024 · 10 likes Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular prescriptions. Some will decline a prescription they consider irregular;…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #57 · Nutrition & Training › Hydration & electrolytes · 25 Aug 2024 · 2 likes Magnesium: deficiency during weight loss is common and symptoms (fatigue, muscle cramps) are nonspecific. Supplementation is inexpensive and low-risk if needed.
High-resolution MS on aggregates and what it can see — one year on Replied, post #21 · Analytics › Mass spectrometry · 14 Aug 2024 · 8 likes On post #17 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
The mass-error checker and its intended scope Replied, post #167 · Data & Tools › Calculators · 30 Jul 2024 · 0 likes post #166 is right about the mechanism and I think understates the practical bit. Why calculators are not medical advice: they do arithmetic. Medical decisions are not…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #119 · Compounds › Retatrutide · 24 Jul 2024 · 11 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #28 · Practice › Dosing & titration · 7 Jul 2024 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
The mass-error checker and its intended scope Replied, post #84 · Data & Tools › Calculators · 29 Jun 2024 · 4 likes Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
Pancreatitis history and the risk calculus — a second dataset Started this topic · Safety › Contraindications · 19 Jun 2024 · 38 likes Pancreatitis history and the risk calculus — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. General question, not a…